However, contrary to the published literature [13, 43] and the predominant view that the presence of TP53 mutations are more frequent in high-grade, large-size, node-positive breast cancers, we did not observe, with the exception of histological grade, a significant association between TP53 mutations and menopausal status, tumor size or nodal status. This evidence concerns the gene TP53 and neoplasm.